Virginie Achim
Papers
2
Total Citations
122
H-Index
2
About
Dr. Virginie Achim is a leading head and neck surgeon whose research focuses on optimizing functional outcomes and quality of life for patients undergoing transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma. Her work has been instrumental in demonstrating that TORS can achieve excellent oncologic control while minimizing the long-term toxicities associated with adjuvant chemoradiotherapy. Her landmark study on long-term functional and quality-of-life outcomes after TORS (90 citations) provides critical evidence that appropriately selected patients can avoid unnecessary adjuvant therapy, preserving swallowing function and overall well-being. Dr. Achim has also advanced perioperative care through her randomized controlled trial on corticosteroids for pain control after TORS (32 citations), a rigorous double-blind, placebo-controlled study that established evidence-based protocols to improve patient recovery. Her contributions have shaped modern treatment paradigms for oropharyngeal cancer, balancing oncologic efficacy with patient-centered outcomes. Dr. Achim’s research continues to influence surgical practice and survivorship care, making her a key figure in the evolution of minimally invasive head and neck cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1
- 2